Yolk Sac Tumor in a Recurrence of Colonic Adenocarcinoma With Shared Mutations in APC and TP53 Genes: A Case Report

Int J Surg Pathol. 2022 Sep;30(6):646-651. doi: 10.1177/10668969211069963. Epub 2022 Jan 5.

Abstract

Only four cases of colorectal adenocarcinoma with a yolk sac tumor (YST) component have been reported in the English literature. No genetic investigation has been performed in these cases. We report a case of colorectal adenocarcinoma in which the recurrent tumor had a YST component. A 49-year-old woman presented with a pelvic tumor three years after endoscopic mucosal resection of sigmoid colon adenocarcinoma. The pelvic tumor consisted of an undifferentiated carcinoma component and a YST component. The serum alpha-fetoprotein level was elevated to 42 ng/mL. Treatment as conventional colorectal carcinoma produced some anticancer effects, but the patient died 14 months after the recurrence and 49 months after the EMR. With the help of the next-generation sequencing results of the recurrent tumor, APC c.835 - 8A > G and TP53 c.524G > A (p.R175H) mutations were identified by direct sequencing in both the primary and the recurrent tumors, confirming the relationship between the two metachronous tumors.

Keywords: APC; TP53; alpha-fetoprotein; colorectal cancer; yolk sac tumor.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / genetics
  • Adenocarcinoma* / pathology
  • Colonic Neoplasms* / genetics
  • Endodermal Sinus Tumor* / diagnosis
  • Endodermal Sinus Tumor* / genetics
  • Endodermal Sinus Tumor* / pathology
  • Female
  • Genes, p53
  • Humans
  • Middle Aged
  • Mutation
  • Pelvic Neoplasms*
  • Tumor Suppressor Protein p53 / genetics

Substances

  • TP53 protein, human
  • Tumor Suppressor Protein p53